000 01810 a2200469 4500
005 20250517133721.0
264 0 _c20170512
008 201705s 0 0 eng d
022 _a1878-1705
024 7 _a10.1016/j.intimp.2017.01.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbo-Elmatty, Dina M
245 0 0 _aMetformin enhancing the antitumor efficacy of carboplatin against Ehrlich solid carcinoma grown in diabetic mice: Effect on IGF-1 and tumoral expression of IGF-1 receptors.
_h[electronic resource]
260 _bInternational immunopharmacology
_cMar 2017
300 _a72-86 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCarboplatin
_xtherapeutic use
650 0 4 _aCarcinoma, Ehrlich Tumor
_xcomplications
650 0 4 _aCaspase 3
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aDiabetes Mellitus, Experimental
_xcomplications
650 0 4 _aDrug Synergism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInsulin-Like Growth Factor I
_xmetabolism
650 0 4 _aIntercellular Signaling Peptides and Proteins
_xmetabolism
650 0 4 _aMetformin
_xtherapeutic use
650 0 4 _aMice
650 0 4 _aMice, Inbred Strains
650 0 4 _aNeovascularization, Pathologic
_xcomplications
650 0 4 _aReceptor, IGF Type 1
_xmetabolism
650 0 4 _aVascular Endothelial Growth Factor A
_xmetabolism
700 1 _aAhmed, Eman A
700 1 _aTawfik, Mona K
700 1 _aHelmy, Seham A
773 0 _tInternational immunopharmacology
_gvol. 44
_gp. 72-86
856 4 0 _uhttps://doi.org/10.1016/j.intimp.2017.01.002
_zAvailable from publisher's website
999 _c26785537
_d26785537